University of Liverpool

University of Dundee

Medizinische Hochschule Hannover

Martin Leuwer

Paul Michael O'Neill

Neil Berry

Chandrakala Pidathala

Gertrud Haeseler

Delia Belelli

Paul O'neill

Jeremy Lambert

The present invention relates to a method of treating pain in a patient in need of such treatment, said method comprising administering to said patient a therapeutically effective amount of a compound of formula (I) or a pharmaceutically acceptable salt or solvate: wherein Q is as defined herein.

Method for treating pain

The present invention relates to compounds of formula I shown below: wherein Q is as defined herein. The compounds of formula I act as selective positive allosteric modulators of strychnine-sensitive alpha 1-glycine receptors. The present invention further relates to the use of these compounds as therapeutic agents for the treatment and/or prevention of diseases or conditions in which strychnine-sensitive alpha 1-glycine receptor activity is implicated (such as, for example, chronic pain. The present invention also relates to processes for the preparation of these compounds and to pharmaceutical compositions comprising them.

Pharmacologically active compounds

The present invention concerns compounds derived from the anaethetic propofol. The compounds may be useful in the treatment of pain, particularly, but not exclusively, chronic pain and central pain sensitisation.

Compounds for use in the treatment of pain

Growing community of inventors

Liverpool, United Kingdom

Martin Leuwer